A study to compare the relative safety and tolerance of orally administered ZDV and D4T in symptomatic HIV-infected children aged 90 days to 6 years. The study also compares the clinical, virologic and immunologic effects of ZDV and d4T monotherapy and will obtain population pharmacokinetic parameters for both drugs.
Showing the most recent 10 out of 211 publications